GUJARAT THEMIS BIOSYN LIMITED
Gujarat Themis Biosyn Limited has completed its qualified institutions placement (QIP) of equity shares. The Fund-Raising Committee of the Company met on August 28, 2026, and passed several resolutions regarding the QIP.
Committee Resolutions
- Approved and declared closure of the QIP issue period on August 28, 2026, following receipt of application forms and funds in the escrow account from eligible qualified institutional buyers
- Determined and approved the issue price for 2,11,86,440 Equity Shares to be allotted to eligible QIBs at ₹354 per Equity Share
- The issue price includes a premium of ₹353 per Equity Share
- The price represents a discount of ₹18.57 per Equity Share (4.98%) on the floor price of ₹372.57 per Equity Share
- The discount is permitted under Regulation 176(1) of Chapter VI of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended
- Approved and finalized the confirmation of allocation note for sending to QIBs receiving allocation
- Approved and adopted the placement document dated August 28, 2026, in connection with the QIP
Additional Details
The Fund-Raising Committee meeting commenced at 8:15 p.m. and concluded at 8:30 p.m. on August 28, 2026.
The QIP was opened on August 25, 2026, as previously intimated to the exchanges via letter dated August 25, 2026.
The placement document has been filed with the National Stock Exchange of India Limited and BSE Limited, and a copy is available on the company's website at www.gtbl.in.
Financial Impact
The QIP involves the issuance of 2,11,86,440 equity shares at ₹354 per share, resulting in total gross proceeds of approximately ₹750 crore. The issuance will dilute the existing share capital by the number of shares issued.